IL6 and inflammatory bowel disease: Furthermore, it could alleviate inflammation in experimentally induced inflammatory bowel disease (IBD) of mice by hindering the production of pro-inflammatory TNFα, interleukin-1ß (IL-1ß), and IL-6 (21).